ACADIA Pharmaceuticals, Inc. Added to NASDAQ Biotechnology Index

Published: May 20, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, announced that it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: ^NBI) effective prior to today’s market open.

Help employers find you! Check out all the jobs and post your resume.

Back to news